Life Technologies: Top Innovative Company in Biomedicine

Life Technologies is one of 10 biomedicine companies included in Technology Review’s 50 Most Innovative Companies (TR50) for 2012 [1].

Life Technologies

Ion Proton Sequencer for Genome Sequencing

Ever since the human genome was sequenced in 2000, there’s been talk of a “$1,000 genome” — the ability to map an individual’s complete genome for one thousand U.S. dollars.

Life Technologies announced yesterday that it has achieved that milestone with the release of the new benchtop Ion Proton Sequencer, which is designed to sequence the entire human genome in a single day (existing DNA sequencing technologies take a week or longer) for $1,000 USD.

Ion Proton Sequencer

1000 Genomes Project Publishes Analysis of Completed Pilot Phase

Small genetic differences between individuals help explain why some people have a higher risk than others for developing illnesses such as diabetes or cancer. Recently in the journal Nature, the 1000 Genomes Project, an international public-private consortium, published the most comprehensive map of these genetic differences, called variations, estimated to contain approximately 95 percent of the genetic variation of any person on Earth.